Abstracts

Replication of HIV-1 in the Central Nervous System of Adults Early After Infection

Background: Viral replication within the central nervous system (CNS) facilitates neurological complications and reflects a potentially important tissue reservoir. The timing of emergence and character of this local CNS replication is unknown. We examined phylogenetic relationships and viral characteristics of paired cerebrospinal fluid (CSF) and blood samples obtained over the first two years of HIV…

PERSISTENT CSF BUT NOT PLASMA HIV RNA IS ASSOCIATED WITH INCREASED RISK OF NEW-ONSET DEPRESSION

Background: Major depressive disorder is the most common neuropsychiatric complication in persons with HIV and is associated with worse clinical outcomes. It is unknown whether detectable cerebrospinal fluid (CSF) human immunodeficiency virus (HIV) ribonucleic acid (RNA) at thresholds ≥50 copies/ml, is associated with increased risk of new-onset depression. We hypothesized a priori that detectable CSF…

CSF Metabolomics Reveals Altered Waste Clearance and Accelerated Aging in HIV Patients with HAND

Background: HIV-associated neurocognitive disorders (HAND) remain prevalent in HIV-infected populations on antiretroviral therapy (ART). Factors associated with increased risk of HAND in HIV patients on suppressive ART include older age, low nadir CD4, and active HCV co-infection, but underlying pathophysiological mechanisms remain unclear. Methodology: Untargeted metabolite profiling of cerebrospinal fluid (CSF) from 90 subjects (36…

Cerebral Small Vessel Disease and HAND in ARV-Treated Subjects

Background: Despite the widespread use of highly active antiretroviral therapy, HIV-associated neurocognitive disorders (HAND) remain prevalent and may be associated with cumulative exposure to antiretroviral (ARV) medications and other factors. We proposed that chronic toxic effects of ARV drugs on the blood vessel walls could contribute to cerebral small vessel disease (CSVD), which even at…

NK Cell Subsets Responding to HIV-Infected Autologous CD4 T Cell in Protective KIR/HLA Genotypes

Background: Genetic and epidemiological studies implicate NK cells in HIV resistance and slow disease progression in infected individuals. This protective effect is achieved by interactions between NK cell surface receptors called KIRs and their ligands, HLA molecules. These interactions are important for NK cells to gain functional potential during a developmental process known as education.…

Do KIR3DL1/HLA-B Combinations Influence ADCC Responses of HIV-1 Infected Slow Progressors?

Background: The *h/*y+B*57 genotype, which encodes high expression Killer Immunoglobulin-like Receptor (KIR)3DL1 variants and HLA-B*57 is the KIR/HLA combination with the strongest effect on slowing time to AIDS and controlling HIV viral load, as compared to Bw6 homozygotes (Bw6hmz). The interaction of 3DL1 with HLA-B*57 is a potent natural killer (NK) cell licensing combination. NK…

Siglec-7 Binds HIV-1 GP120 and Facilitates Infection of CD4pos T Cells and Macrophages

Background: Sialic acid-binding Ig-like lectin-7 (Siglec-7) expression is strongly reduced on natural killer (NK) cells from HIV-1 infected viremic patients. To investigate the mechanism(s) underlying this phenomenon, we hypothesized that Siglec-7 could directly interact with the HIV-1 envelope (Env) glycoprotein 120 (gp120), thus contributing to the infection of target cells. Methodology: The binding of Siglec-7…